Cargando…

Protocol for the Stimulating β(3)-Adrenergic Receptors for Peripheral Artery Disease (STAR-PAD) trial: a double-blinded, randomised, placebo-controlled study evaluating the effects of mirabegron on functional performance in patients with peripheral arterial disease

INTRODUCTION: There is currently only one approved medication effective at improving walking distance in people with intermittent claudication. Preclinical data suggest that the β(3)-adrenergic receptor agonist (mirabegron) could be repurposed to treat intermittent claudication associated with perip...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bubb, Kristen J, Harmer, Jason A, Finemore, Meghan, Aitken, Sarah Joy, Ali, Zara S, Billot, Laurent, Chow, Clara, Golledge, Jonathan, Mister, Rebecca, Gray, Michael P, Grieve, Stuart M, Hamburg, Naomi, Keech, Anthony C, Patel, Sanjay, Puttaswamy, Vikram, Figtree, Gemma A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479946/ https://www.ncbi.nlm.nih.gov/pubmed/34588252 http://dx.doi.org/10.1136/bmjopen-2021-049858

Ejemplares similares

A hidden problem: peripheral artery disease in women
por: Kavurma, Mary M, et al.
Publicado: (2023)

Endothelial cell dysfunction: Implications for the pathogenesis of peripheral artery disease
por: Kavurma, Mary M., et al.
Publicado: (2022)

β (3) Adrenergic Receptor Stimulation Promotes Reperfusion in Ischemic Limbs in a Murine Diabetic Model
por: Bubb, Kristen J., et al.
Publicado: (2021)

Oxidative Stress in Peripheral Arterial Disease (PAD) Mechanism and Biomarkers
por: Signorelli, Salvatore Santo, et al.
Publicado: (2019)

Determinants of exercise calf muscle perfusion in Peripheral Arterial Disease (PAD)
por: Gonzalez, Jorge A, et al.
Publicado: (2016)

Pathophysiology of Peripheral Arterial Disease (PAD): A Review on Oxidative Disorders
por: Signorelli, Salvatore Santo, et al.
Publicado: (2020)

Dietary Risk Factors and Eating Behaviors in Peripheral Arterial Disease (PAD)
por: Cecchini, Andrea Leonardo, et al.
Publicado: (2022)

Evidence-Based Recommendations for Medical Management of Peripheral Artery Disease
por: Golledge, Jonathan, et al.
Publicado: (2021)

The Need for Translational Research to Advance Peripheral Artery Disease Management
por: Moxon, Joseph V., et al.
Publicado: (2015)

Selectivity and Maximum Response of Vibegron and Mirabegron for β(3)-Adrenergic Receptors
por: Brucker, Benjamin M., et al.
Publicado: (2022)

A Review of the Pathophysiology and Potential Biomarkers for Peripheral Artery Disease
por: Krishna, Smriti Murali, et al.
Publicado: (2015)

Presentation and outcomes of indigenous Australians with peripheral artery disease
por: Singh, Tejas P., et al.
Publicado: (2018)

A modern day perspective on smoking in peripheral artery disease
por: Behrooz, Leili, et al.
Publicado: (2023)

The sensitivity and specificity of the toe brachial index in detecting peripheral arterial disease
por: Craike, Peta, et al.
Publicado: (2013)

Sex‐Based Differences in Outcomes Following Peripheral Artery Revascularization: Insights From VOYAGER PAD
por: Hess, Connie N., et al.
Publicado: (2022)

The Impact of Peripheral Artery Disease (PAD) on Lower Limb Kinematics in Type 2 Diabetes Mellitus
por: Thorne, Claire Saliba, et al.
Publicado: (2021)

Association of Serum Lipoprotein (a) With the Requirement for a Peripheral Artery Operation and the Incidence of Major Adverse Cardiovascular Events in People With Peripheral Artery Disease
por: Golledge, Jonathan, et al.
Publicado: (2020)

Patient Endothelial Colony-Forming Cells to Model Coronary Artery Disease Susceptibility and Unravel the Role of Dysregulated Mitochondrial Redox Signalling
por: Besnier, Marie, et al.
Publicado: (2021)

The Association of Visceral Adiposity with Cardiovascular Events in Patients with Peripheral Artery Disease
por: Cronin, Oliver, et al.
Publicado: (2013)

Medical Resource Consumption and Quality of Life in Peripheral Arterial Disease in Korea: PAD Outcomes (PADO) Research
por: Rha, Seung-Woon, et al.
Publicado: (2018)

Explaining Racial Disparities in Amputation Rates for the Treatment of Peripheral Artery Disease (PAD) Using Decomposition Methods
por: Mustapha, J. A., et al.
Publicado: (2017)

Individuals with Peripheral Artery Disease (PAD) and Type 1 Diabetes Are More Likely to Undergo Limb Amputation than Those with PAD and Type 2 Diabetes
por: Jain, Nidhi, et al.
Publicado: (2020)

National and subnational estimation of the prevalence of peripheral artery disease (PAD) in China: a systematic review and meta-analysis
por: Song, Peige, et al.
Publicado: (2019)

Oxygen-Ozone (O(2)-O(3)) Therapy in Peripheral Arterial Disease (PAD): A Review Study
por: Juchniewicz, Hanna, et al.
Publicado: (2020)

Association between complete revascularization of the coronary artery and clinical outcomes in peripheral artery disease: a sub-analysis of the I-PAD Nagano registry
por: Kato, Tamon, et al.
Publicado: (2023)

Endothelial Dysfunction of Patients with Peripheral Arterial Disease Measured by Peripheral Arterial Tonometry
por: Igari, Kimihiro, et al.
Publicado: (2016)

Recent Update on Peripheral Arterial Endovascular Therapy for Peripheral Arterial Occlusive Disease
por: Tanaka, Ryoichi
Publicado: (2020)

Body‐weight‐independent glucose‐lowering effect of the β3‐adrenergic receptor agonist mirabegron in humans
por: Waki, Hironori, et al.
Publicado: (2021)

Mirabegron, a Selective β3-Adrenergic Receptor Agonist, as a Potential Anti-Obesity Drug
por: Dąbrowska, Anna Maria, et al.
Publicado: (2023)

Medial artery calcification in peripheral artery disease
por: Kim, Tanner I., et al.
Publicado: (2023)

Functional and transcriptomic analysis of extracellular vesicles identifies calprotectin as a new prognostic marker in peripheral arterial disease (PAD)
por: Saenz-Pipaon, Goren, et al.
Publicado: (2020)

The Influence of Individualized Three-Dimensional Holographic Models on Patients’ Knowledge Qualified for Intervention in the Treatment of Peripheral Arterial Disease (PAD)
por: Skórka, Patryk, et al.
Publicado: (2023)

Control of modifiable risk factors and major adverse cardiovascular events in people with peripheral artery disease and diabetes
por: Golledge, Jonathan, et al.
Publicado: (2021)

4281 Developing a predictive tool to detect peripheral artery disease (PAD): Examining patient-reported symptoms in ischemic versus non-ischemic conditions (PREDICT PAD)
por: Brown, Rebecca, et al.
Publicado: (2020)

β3 adrenergic agonism: A novel pathway which improves right ventricular‐pulmonary arterial hemodynamics in pulmonary arterial hypertension
por: Karimi Galougahi, Keyvan, et al.
Publicado: (2023)

Peripheral arterial disease in the elderly
por: Aronow, Wilbert S
Publicado: (2007)

Peripheral Artery Disease and Stroke
por: Zito, Concetta, et al.
Publicado: (2020)

Association of impaired fasting glucose, diabetes and their management with the presentation and outcome of peripheral artery disease: a cohort study
por: Golledge, Jonathan, et al.
Publicado: (2014)

Peripheral arterial disease : a physician's approach
por: Richards, Robert Lawrence
Publicado: (1970)

The PodPAD project: a podiatry-led integrated pathway for people with peripheral arterial disease in the UK – a pilot study
por: Farndon, Lisa, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_qgnuulegcjebept5cbq1it68gf